EU Listing Act: Easier Access to Public Markets

Key Takeaways

• The EU Listing Act simplifies prospectus, market abuse, and research rules to lower listing costs.
• It introduces multiple-vote shares for companies listing on multilateral trading facilities for the first time.
• A common mistake is treating it as one law when it is three separate legislative acts.
• Lighter disclosure changes how much information investors get when they buy newly listed shares.

What It Is: The EU Listing Act Package

The EU Listing Act is not a single statute. It is a package published in the EU Official Journal on 14 November 2024, made up of three acts. The Listing Regulation (EU) 2024/2809 amends the Prospectus Regulation, the Market Abuse Regulation (MAR), and the Markets in Financial Instruments Regulation (MiFIR). The Listing Directive (EU) 2024/2811 changes MiFID rules on investment research. The Multiple-Vote Shares Directive (EU) 2024/2810 is a brand-new directive on dual-class voting.

Together they reduce the paperwork and ongoing obligations that have made European public markets less attractive than private capital or a US listing.

The Intuition

Going public is expensive. A full prospectus can run hundreds of pages, and the market-abuse rules add ongoing compliance once a company is listed. Many founders also fear losing control once outside shareholders arrive.

The Listing Act attacks all three pain points. It trims the prospectus, eases some MAR obligations, and lets founders keep voting control through enhanced-vote shares. The trade-off is that investors accept somewhat lighter disclosure and, in dual-class firms, less voting power per share.

How It Works

On the prospectus, the rules cut length and standardize format. Risk factors must be specific rather than generic disclaimers, and the requirement to rank every risk is replaced by listing the most material risks in a limited set of categories. The old EU Growth Prospectus becomes the EU Growth Issuance Prospectus, and the simplified secondary-issue and recovery prospectuses are merged into a new EU Follow-On Prospectus for companies already listed.

The Multiple-Vote Shares Directive lets companies seeking admission to a multilateral trading facility (MTF), including SME growth markets, use shares carrying extra votes. Member states must set a ratio between the votes on multiple-vote shares and ordinary shares, so control cannot be unlimited.

The package applies in phases, with key application dates of 4 December 2024, 5 March 2026, and 5 June 2026. Member states have until 5 December 2026 to write the Multiple-Vote Shares Directive into national law.

Worked Example

Imagine a founder-led software firm with 50 million euros of revenue that wants to raise growth capital but fears a hostile takeover after listing. Before the Listing Act, the firm faced a long prospectus and a one-share-one-vote rule on most venues, so it considered staying private.

Under the Listing Act, the firm lists on an SME growth market using an EU Growth Issuance Prospectus, a shorter document with categorized risk factors. The founder issues multiple-vote shares within the national ratio cap, keeping voting control while selling economic ownership to new investors. The lighter rules make the public route viable.

Common Mistakes

1. Treating it as one law. The Listing Act is three acts touching different regulations. A change to the prospectus rules does not automatically change MAR or MiFID research rules.

2. Assuming lighter disclosure means no risk disclosure. Prospectuses are shorter, but issuers must still present specific, material risks. Generic disclaimers are now explicitly discouraged.

3. Ignoring the voting trade-off. Multiple-vote shares let founders keep control, so ordinary shareholders may hold economic risk with limited say. Read the voting ratio before you buy.

4. Forgetting the phased timeline. Provisions apply on staggered dates through 2026. A rule may exist on paper before it actually binds issuers.

5. Overlooking national transposition. The Multiple-Vote Shares Directive needs each member state to legislate by 5 December 2026, so the detail varies country by country.

Frequently Asked Questions

What is the EU Listing Act in simple terms? The EU Listing Act is a set of reforms that make listing on European stock markets cheaper and simpler. It shortens prospectuses, eases listed-company rules, and allows founders to keep extra voting power.

How does the EU Listing Act affect investment decisions? It can mean shorter prospectuses and more dual-class companies. You may get less disclosure and, in some firms, fewer votes per share, so you should check governance terms before buying newly listed shares.

What is a real-world example of the EU Listing Act in action? A founder-led SME could list on an SME growth market using the new EU Growth Issuance Prospectus and issue multiple-vote shares to keep control while raising outside capital.

How can investors use the EU Listing Act effectively? Treat the lighter prospectus as a reason to do more independent due diligence, and read the voting structure of any dual-class issuer to understand how much influence your shares carry.

How is the EU Listing Act different from a single prospectus reform? A prospectus reform changes only disclosure documents. The Listing Act also rewrites market-abuse and research rules and introduces multiple-vote shares, so it reshapes governance, not just paperwork.

Sources

1. ESMA. "Listing Act." https://www.esma.europa.eu/esmas-activities/listing-act
2. AMF. "The Listing Act: Facilitating Companies' Access to European Capital Markets." https://www.amf-france.org/en/news-publications/depth/listing-act
3. PwC Legal. "EU's final adoption of the Listing Act package." https://legal.pwc.de/en/news/articles/eu-s-final-adoption-of-the-listing-act-package
4. Cleary Gottlieb. "The Listing Act: New Developments for Financial Markets in the European Union." https://www.clearygottlieb.com/news-and-insights/publication-listing/the-listing-act-new-developments-for-financial-markets-in-the-european-union

Disclaimer

This article is educational content only and is not financial advice. Nothing here is a recommendation to buy, sell, or hold any security. Consult a licensed advisor before making investment decisions.